Fraxamoside
Fraxamoside is a competitive xanthine oxidase inhibitor with an IC50 of 16.1 μM and a Ki of 0.9 μM[1].
Product Specifications
CAS Number
[326594-34-7]
UNSPSC
12352005
Target
Xanthine Oxidase
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/fraxamoside.html
Solubility
10 mM in DMSO
Smiles
C/C=C1[C@@]2([H])C(C(OC)=O)=CO[C@@]\1([H])O[C@]3([H])O[C@]([C@H]([C@@H]([C@H]3O)O)O)([H])CO[C@H](C4=CC(O)=C(C=C4)O)COC(C2)=O
Molecular Formula
C25H30O13
Molecular Weight
538.50
References & Citations
[1]Vitale RM, et al. Structure-activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor. J Enzyme Inhib Med Chem. 2017 Dec;32 (1) :345-354.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15201619 1 Vial
Lentiviral mouse Amtn shRNA (UAS) - Lentiviral mouse Amtn shRNA (UAS) plasmid
Ask
View Details 
MBS2029548-01 0.01 mg
Recombinant Protein Tyrosine Phosphatase Receptor Type Q (PTPRQ)
Ask
View Details MBS2029548-02 0.05 mg
Recombinant Protein Tyrosine Phosphatase Receptor Type Q (PTPRQ)
Ask
View Details 
MBS2029548-03 0.1 mg
Recombinant Protein Tyrosine Phosphatase Receptor Type Q (PTPRQ)
Ask
View Details MBS2029548-04 0.2 mg
Recombinant Protein Tyrosine Phosphatase Receptor Type Q (PTPRQ)
Ask
View Details